title: Levosimendan or enoximone in refractory cardiogenic shock?
authors.forename: Preben G
authors.initials: PG
authors.lastname: Berthelsen
mesh_terms: D002316:Cardiotonic Agents / Q000627:therapeutic use*; D017335:Enoximone / Q000627:therapeutic use*; D006801:Humans; D006835:Hydrazones / Q000627:therapeutic use*; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use*; D011724:Pyridazines / Q000627:therapeutic use*; D012770:Shock, Cardiogenic / Q000188:drug therapy*; D000077464:Simendan
chemical_list: D002316:Cardiotonic Agents; D006835:Hydrazones; D010726:Phosphodiesterase Inhibitors; D011724:Pyridazines; D000077464:Simendan; D017335:Enoximone